Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Advantig-105: Phase Ib dose-expansion study of ociperlimab (OCI) plus tislelizumab (TIS) with chemotherapy (CT) in patients (pts) with metastatic oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC)

Authors
Sun, M.Spigel, D. R.Lee, Y-J.Yoon, H.Liu, Y.Ahern, E.Harris, S.Lee, G-W.Yan, D.Chen, J.Shiah, H-S.Deng, T.Zheng, H.Tan, W.Zhou, Z.Wang, R.Ba, Y.
Issue Date
Oct-2023
Publisher
ELSEVIER
Citation
ANNALS OF ONCOLOGY, v.34, pp S862 - S863
Indexed
SCIE
SCOPUS
Journal Title
ANNALS OF ONCOLOGY
Volume
34
Start Page
S862
End Page
S863
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/69002
DOI
10.1016/j.annonc.2023.09.1445
ISSN
0923-7534
1569-8041
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Gyeong Won photo

Lee, Gyeong Won
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE